跳至主要内容
临床试验/JPRN-jRCTs071190028
JPRN-jRCTs071190028已完成未知

Effects of plasmalogen on mental status, body composition and athletic performance among young adult athletes - Athletes Plasmalogen Trial

Fujino Minoru0 个研究点目标入组 42 人开始时间: 2019年10月8日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

Effects of plasmalogen (Pls) use for 4 weeks (2 mg per day) on POMS2, other psychological measures, and biological markers (blood Pls, plasma BDNF, urine 8-OHdG) were evaluated in a randomized placebo-controlled trial of 40 university athletes. The change in POMS2 TMD (primary outcome) did not show a statistically significant between-group difference. AH (anger-hostility) and FI (fatigue-inertia) of the POMS2 subscales showed greater decrease in Pls group than in placebo group (P <0.05).

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 22age old(—)
性别
Male

入选标准

  • To meet all of the three conditions:
  • 1) male students belonging to sport clubs of Kyushu Sangyo University;
  • 2) unmarried men aged 18-22 years at the time of provision of informed consent; and
  • 3) those who are able to provide wriiten informed consent.

排除标准

  • To meet at least one of the following conditions:
  • 1) those under medical treatment;
  • 2) those who are participating in an other clinical trial;
  • 3) those with shellfish allergy
  • 4) those who are judged as ineligible by a principal physican investigator or a designated supervising investigator

研究者

发起方
Fujino Minoru

相似试验